FDA Clearance Tracker · P840001-S623
Master Restore, Itrel, Synergy, Intellis, Vanta and Inceptiv Spinal Cord Stimulation Systems and Pisces, Specify
Last checked: Nov 20, 2026Latest source record: Jul 1, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jul 1, 2026
Approved
Time to decision
86 days
Received Apr 6, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P840001-S623
- Device name
- Master Restore, Itrel, Synergy, Intellis, Vanta and Inceptiv Spinal Cord Stimulation Systems and Pisces, Specify
- Applicant
- Medtronic Neuromodulation
- Applicant location
- Minneapolis, MN
- Received
- Apr 6, 2026
- Decided
- Jul 1, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P840001
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for a software update to Model A71200 Vanta / Sequentia LT Clinician Programmer Application from version 2.0 to version 2.1 for spinal cord stimulation (SCS).
Source documents
Other decisions for Medtronic Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P240011 · Decided Sep 18, 2025 · 532 days after receipt
Device type: Stimulator, tibial, electrical, implantable, for urinary incontinence (QPT) · GI, Urology & Nephrology
- Restore, Itrel, Synergy, Intellis, and Vanta Spinal Cord Stimulation Systems, Pisces, Specify and Vectris Spinal Cord StPMA supplement
P840001-S469 · Decided Jan 21, 2022 · 164 days after receipt · Panel Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
- SureTune4 SoftwareNew device typeDe Novo
DEN210003 · Decided Aug 23, 2021 · 201 days after receipt
Device type: Brain Stimulation Programming Planning Software. (QQC) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.